A novel phospholipid derivative of indomethacin, DP-155 [mixture of 1-steroyl and 1-palmitoyl-2-{4-[1-(p-chlorobenzoyl)-5-methoxy-2-methyl-3-indolyl acetamido]butanoyl}-sn-glycero-3-phosophatidyl choline], shows superior safety and similar efficacy in reducing brain amyloid β in an Alzheimer's disease model (vol 318, pg 1248, 2006)

被引：0
|
作者：
Dvir, E.
Friedman, J. E.
Lee, J. Y.
Koh, J. Y.
Younis, F.
Raz, S.
Shapiro, I
Hoffman, A.
Dahan, A.
Rosenberg, G.
Angel, I
Kozak, A.
Duvdevani
机构：
来源：
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS | 2006年 / 319卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：1492 / 1492
页数：1
相关论文
共 1 条
  • [1] A novel phospholipid derivative of indomethacin, DP-155 [mixture of 1-steroyl and 1-palmitoyl-2-{4-[ 1-(p-chlorobenzoyl)-5-methoxy-2-methyl-3-indolyl acetamido]butanoyl}-sn-glycero-3-phosophatidyl choline], shows superior safety and similar efficacy in reducing brain amyloid β in an Alzheimer's disease model
    Dvir, E.
    Friedman, J. E.
    Lee, J. Y.
    Koh, J. Y.
    Younis, F.
    Raz, S.
    Shapiro, I.
    Hoffman, A.
    Dahan, A.
    Rosenberg, G.
    Angel, I.
    Kozak, A.
    Duvdevani, R.
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2006, 318 (03): : 1248 - 1256
1